HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shi-Rong Zhang Selected Research

LC capilliposide

1/2017Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.
1/2014Capilliposide Isolated from Lysimachia capillipes Hemsl. Induces ROS Generation, Cell Cycle Arrest, and Apoptosis in Human Nonsmall Cell Lung Cancer Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shi-Rong Zhang Research Topics

Disease

12Neoplasms (Cancer)
08/2021 - 01/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 01/2017
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 04/2018
4Adenocarcinoma
01/2019 - 04/2018
3Neoplasm Metastasis (Metastasis)
08/2021 - 02/2017
3Glioma (Gliomas)
03/2021 - 01/2018
2Carcinogenesis
03/2021 - 01/2018
2Carcinoma (Carcinomatosis)
03/2021 - 01/2018
2Lung Neoplasms (Lung Cancer)
06/2020 - 01/2014
1Pituitary Neoplasms (Pituitary Adenoma)
10/2019
1Ataxia Telangiectasia (Louis Bar Syndrome)
08/2018
1Hyperthermia
08/2018
1Brain Neoplasms (Brain Tumor)
02/2017
1Hepatitis B
09/2015
1Hepatocellular Carcinoma (Hepatoma)
01/2014

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
06/2020 - 04/2018
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2021 - 04/2018
2Long Noncoding RNAIBA
03/2021 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2018
2LC capilliposideIBA
01/2017 - 01/2014
1Cadherins (E-Cadherin)IBA
08/2021
1Fibronectins (Fibronectin)IBA
08/2021
1Histamine Receptors (Histamine Receptor)IBA
08/2021
1chalcomoracinIBA
06/2020
1Antineoplastic Agents (Antineoplastics)IBA
06/2020
1Radiation-Sensitizing AgentsIBA
06/2020
1ChemokinesIBA
10/2019
1Ephrin-A1 (Ephrin A1)IBA
10/2019
1XenobioticsIBA
10/2019
1CollagenIBA
10/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2018
1Phosphotransferases (Kinase)IBA
08/2018
1Matrix Metalloproteinases (MMPs)IBA
08/2018
1LigandsIBA
04/2018
1CA-125 Antigen (CA 125 Antigen)IBA
04/2018
1Carcinoembryonic AntigenIBA
04/2018
1Tumor Biomarkers (Tumor Markers)IBA
01/2018
1AfatinibIBA
02/2017
1Gefitinib (Iressa)FDA Link
01/2017
1Immunoglobulins (Immunoglobulin)IBA
09/2015
1NucleosidesIBA
09/2015
1NucleotidesIBA
09/2015
1hepatitis B hyperimmune globulinIBA
09/2015
1Sorafenib (BAY 43-9006)FDA Link
01/2014

Therapy/Procedure

5Therapeutics
06/2020 - 01/2014
2Pancreatectomy
02/2019 - 01/2019
1Radiotherapy
06/2020
1Neoadjuvant Therapy
01/2019
1Combined Modality Therapy
01/2019
1Transjugular Intrahepatic Portasystemic Shunt
12/2018
1Adjuvant Chemoradiotherapy
09/2018
1Immunotherapy
04/2018
1Liver Transplantation
09/2015